Labcorp CFO Glenn Eisenberg Announces Plans to Retire

Julia Wang Named Chief Financial Officer Beginning December 2, 2024 BURLINGTON, N.C. , Nov. 19, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that Executive Vice President and Chief Financial Officer (CFO) Glenn

Bola Oyegunwa, Ph.D., MBA, MMB

Bola Oyegunwa, Ph.D., has served as Labcorp’s Executive Vice President and Chief Information and Technology Officer since November 2024.

Labcorp Launches New Global Trial Connect Enhancements to Streamline Site Workflow

BURLINGTON, N.C. (November 12, 2024) — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today enhancements to Global Trial Connect, a suite of digital, data and operational solutions available to Labcorp Central Laboratory clients aimed at increasing the speed of clinical trials at the heart of clinical research – investigator sites.  

Labcorp Announces Availability of First Companion Diagnostic Assay to Identify Gastric Cancer Patients Eligible for Targeted Treatment with VYLOY™

BURLINGTON, N.C. (October 31, 2024) – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced its readiness to begin providing the Roche VENTANA® CLDN18 (43-14A) RxDx Assay in the United States. 

Labcorp Announces 2024 Third Quarter Results

Updates Full-Year Guidance Results from Continuing Operations for third quarter 2024 versus last year: Revenue: $3.28 billion versus $3.06 billion Diluted EPS: $2.00 versus $2.11 Adjusted EPS: $3.50 versus $3.38 Free Cash Flow: $162 million versus $171 million Updated Full-Year 2024 Guidance:

Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test

Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S. , offering First to Know® Syphilis Test nationwide BURLINGTON, N.C. , Oct 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced

Labcorp Declares Quarterly Dividend

BURLINGTON, N.C. , Oct. 10, 2024 /PRNewswire/ -- Labcorp  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on December 13, 2024 ,

Ethisphere Recognizes Labcorp with Compliance Leader Verification™

Phoenix, AZ, October 8, 2024 – Ethisphere, a global leader in defining and advancing the standards of ethical business practices, announced today that Labcorp earned the coveted Compliance Leader Verification from August 2024 through December 2025.

Leveraging telehealth to serve underrepresented populations: Bridging gaps and promoting health equity

Learn how telehealth has immense potential as a critical tool for expanding access to healthcare, especially for underrepresented populations facing health disparities. By leveraging telehealth services grounded in principles of value-based care and population health management, we can bridge gaps in care and make definitive progress toward health equity.

Labcorp to Announce Third Quarter Financial Results on October 24, 2024

BURLINGTON, N.C. , Sept. 24, 2024 /PRNewswire/ -- Labcorp  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2024 before the market opens on Thursday, October 24, 2024 .